Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa

Journal of Investigative Dermatology

Volumn 131, Issue 4, 2011, Pages 848-856

  Tolar, Jakub ^a,c   Xia, Lily ^a   Riddle, Megan J ^a   Lees, Chris J ^a   Eide, Cindy R ^a   McElmurry, Ron T ^a   Titeux, Matthias ^b   Osborn, Mark J ^a   Lund, Troy C ^a   Hovnanian, Alain ^b   Wagner, John E ^a   Blazar, Bruce R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c MMC 366   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 7;

ARTICLE; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL LINEAGE; CELL RENEWAL; CONTROLLED STUDY; DERMOEPIDERMAL JUNCTION; EPIDERMOLYSIS BULLOSA DYSTROPHICA; EPIGENETICS; EROSION; FIBROBLAST; GENODERMATOSIS; HUMAN; HUMAN CELL; KERATINOCYTE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA; SKIN CELL; WILD TYPE;

EID: 79952765436     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.346     Document Type: Article

References (39)

1. Aasen T, Raya A, Barrero MJ et al. (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26:1276-84
2. Abercrombie EM, Mather CA, Hon J et al. (2008) Recessive dystrophic epidermolysis bullosa. Part 2: care of the adult patient. Br J Nurs 17:S6, S8, S10 passim
3. Chen M, Kasahara N, Keene DR et al. (2002) Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa. Nat Genet 32:670-5 (Pubitemid 35435183)
4. Chino T, Tamai K, Yamazaki T et al. (2008) Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance. Am J Pathol 173:803-14
5. Conget P, Rodriguez F, Kramer S et al. (2010) Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy 12:429-31
6. Dang N, Murrell DF (2008) Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa. Exp Dermatol 17:553-68
7. De Luca M, Pellegrini G, Mavilio F (2009) Gene therapy of inherited skin adhesion disorders: a critical overview. Br J Dermatol 161:19-24
8. Ebert AD, Yu J, Rose JFF et al. (2009) Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457:277-81
9. Ferrari S, Pellegrini G, Matsui T et al. (2006) Gene therapy in combination with tissue engineering to treat epidermolysis bullosa. Expert Opin Biol Ther 6:367-78
10. Fine JD, Eady RA, Bauer EA et al. (2008) The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 58:931-50
11. Fivenson DP, Scherschun L, Choucair M et al. (2003) Graftskin therapy in epidermolysis bullosa. J Am Acad Dermatol 48:886-92 (Pubitemid 36706222)
12. Freberg CT, Dahl JA, Timoskainen S et al. (2007) Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract. Mol Biol Cell 18:1543-53 (Pubitemid 46717539)
13. Kohn DB, Sadelain M, Glorioso JC (2003) Occurrence of leukaemia following gene therapy of X-linked SCID. Nat Rev Cancer 3:477-88 (Pubitemid 37328836)
14. Maherali N, Ahfeldt T, Rigamonti A et al. (2008a) A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 3:340-5
15. Maherali N, Ahfeldt T, Rigamonti A et al. (2008b) A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 3:340-5
16. Mecklenbeck S, Compton SH, Mejia JE et al. (2002) A microinjected COL7A1-PAC vector restores synthesis of intact procollagen VII in a dystrophic epidermolysis bullosa keratinocyte cell line. Hum Gene Ther 13:1655-62 (Pubitemid 35034685)
17. Mellerio JE, Weiner M, Denyer JE et al. (2007) Medical management of epidermolysis bullosa: Proceedings of the IInd International Symposium on Epidermolysis Bullosa, Santiago, Chile, 2005. Int J Dermatol 46:795-800 (Pubitemid 47162777)
18. Okita K, Nakagawa M, Hyenjong H et al. (2008) Generation of mouse induced pluripotent stem cells without viral vectors. Science 322:949-53
19. Ortiz-Urda S, Lin Q, Green CL et al. (2003) Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue. J Clin Invest 111:251-5 (Pubitemid 36105924)
20. Ortiz-Urda S, Thyagarajan B, Keene DR et al. (2002) Stable nonviral genetic correction of inherited human skin disease. Nat Med 8:1166-70 (Pubitemid 35175973)
21. Park IH, Arora N, Huo H et al. (2008a) Disease-specific induced pluripotent stem cells. Cell 134:877-86
22. Park IH, Zhao R, West JA et al. (2008b) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141-6
23. Park IH, Zhao R, West JA et al. (2008c) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141-6
24. Raya A, Rodriguez-Piza I, Guenechea G et al. (2009) Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460:53-9
25. Scharf SJ, Smith AG, Hansen JA et al. (1995) Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers. Blood 85:1954-63
26. Shimizu H, McGrath JA, Christiano AM et al. (1996) Molecular basis of recessive dystrophic epidermolysis bullosa: genotype/phenotype correlation in a case of moderate clinical severity. J Invest Dermatol 106:119-24 (Pubitemid 26052057)
27. Takahashi K, Yamanaka S (2006a) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-76 (Pubitemid 44233629)
28. Takahashi K, Yamanaka S (2006b) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-76 (Pubitemid 44233629)
29. Titeux M, Pendaries V, Zanta-Boussif MA et al. (2010) SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa. Mol Ther 18:1509-18
30. Tolar J, Ishida-Yamamoto A, Riddle M et al. (2009) Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood 113:1167-74
31. Tulpule A, Lensch MW, Miller JD et al. (2010) Knockdown of Fanconi anemia genes in human embryonic stem cells reveals early developmental defects in the hematopoietic lineage. Blood 115:3453-62
32. Varki R, Sadowski S, Uitto J et al. (2007) Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes. J Med Genet 44:181-92 (Pubitemid 46580527)
33. Vierbuchen T, Ostermeier A, Pang ZP et al. (2010) Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463:1035-42
34. Wong T, Gammon L, Liu L et al. (2008) Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 128: 2179-89
35. Woodley DT, Keene DR, Atha T et al. (2004a) Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa. Nat Med 10:693-5 (Pubitemid 38937633)
36. Woodley DT, Keene DR, Atha T et al. (2004b) Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo. Mol Ther 10:318-26 (Pubitemid 39117876)
37. Woodley DT, Remington J, Huang Y et al. (2007) Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing. Mol Ther 15:628-35
38. Yan WF, Murrell DF (2010) Fibroblast-based cell therapy strategy for recessive dystrophic epidermolysis bullosa. Dermatol Clin 28:367-70, xii
39. Yu J, Vodyanik MA, Smuga-Otto K et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-20